Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/8249
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSitwala, Nikum D.-
dc.contributor.authorVyas, Vivek K.-
dc.contributor.authorVariya, Bhavesh C.-
dc.contributor.authorPatel, Snehal S.-
dc.contributor.authorMehta, Chirag C.-
dc.contributor.authorRana, Dharmraj N.-
dc.contributor.authorGhate, Manjunath D.-
dc.date.accessioned2019-03-27T08:51:00Z-
dc.date.available2019-03-27T08:51:00Z-
dc.date.issued2017-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/8249-
dc.descriptionBioorganic Chemistry; 75 (2017): 118–126en_US
dc.description.abstractThe synthesis of 1,2,5-trisubstituted benzimidazole derivatives was carried out using liquid phase combinatorial approach using soluble polymer assisted support (PEG5000). Synthesised compounds were characterised by FTIR, ESI-MS, 1H NMR and 13C NMR. The purity of compounds was confirmed with HPLC analysis. Compounds were also docked into the binding site of human dihydroorotate dehydrogenase (hDHODH). The synthesised compounds were screened for hDHODH enzyme inhibition assay using brequinar as standard compound. The synthesised compounds demonstrated comparative biologicalactivity. Synthesised compounds 8d and 8e demonstrated IC50 value of 81 ± 2 nM and 97 ± 2 nM, respectively.en_US
dc.publisherElsevieren_US
dc.relation.ispartofseriesIPFP0282;-
dc.subjectBenzimidazole derivativesen_US
dc.subjectLiquid phase combinatorial synthesisen_US
dc.subjectHuman dihydroorotate dehydrogenase (hDHODH)en_US
dc.subjecthDHODH inhibitorsen_US
dc.titleLiquid phase combinatorial synthesis of 1,2,5-trisubstituted benzimidazole derivatives as human DHODH inhibitorsen_US
dc.typeFaculty Papersen_US
Appears in Collections:Faculty Papers

Files in This Item:
File Description SizeFormat 
IPFP0282.pdfIPFP02822.04 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.